Drug
Methylnaltrexone
Methylnaltrexone: highest development phase Phase 3, developed by Bausch Health. 4 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| SC Methylnaltrexone (MNTX) NCT01367600 | Phase 3 | Terminal Illness |
| IV methylnaltrexone (MNTX) NCT01367483 | Phase 1 | Healthy Male Volunteers |
| SC Methylnaltrexone (MNTX) NCT01367496 | Phase 1 | Healthy Subjects |
| methylnaltrexone NCT01366378 | Phase 1 | Healthy Adult Subjects |
Latest
No recent events.
Follow Methylnaltrexone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.